Welcome to our dedicated page for Volato Group SEC filings (Ticker: SOAR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Volato Group, Inc. filings document material-event disclosures for a public private aviation company, including material agreements, shareholder voting matters, capital-structure disclosures, governance matters and operating and financial results. The company's recent 8-K record includes disclosures involving Class A common stock transactions, unregistered securities activity, registration obligations and the termination of an at-the-market sales agreement.
Volato's filings also describe governance and reporting matters such as board and committee appointments, changes in the independent registered public accounting firm, going-concern language in audit reporting, internal-control matters and emerging growth company status. The filing record reflects the company's corporate structure, public security disclosures and recurring reporting obligations as a Delaware operating company.
Catheter Precision, Inc. reports acquiring 2,941,176 shares of Volato Group, Inc. common stock. The filing states the shares were acquired pursuant to a Securities Purchase Agreement dated June 7, 2026 with the purchase closing on June 18, 2026. The reporting person beneficially owns 2,941,176 shares, representing 7.5% of the class based on the issuer's statement that 39,336,982 shares were outstanding after the private placement.
The Schedule 13G lists sole voting and dispositive power over the reported shares in the name of Catheter Precision, Inc. and is signed by the issuer's Chief Financial Officer on June 26, 2026.
Volato Group, Inc. registers the resale of up to 6,500,000 shares of Class A common stock by selling stockholders pursuant to a Securities Purchase Agreement dated June 7, 2026.
The shares were issued at $0.34 per share and the Company received aggregate gross proceeds of $2,210,000 at issuance. The resale registration permits the identified selling stockholders to sell their shares from time to time; the Company will not receive proceeds from resales under this prospectus. Shares outstanding were 32,836,982 as of June 16, 2026. The registration covers resale only and includes selling holders such as Catheter Precision, Inc. and SEG Opportunity Fund, LLC.
Volato Group, Inc. closed a previously announced private placement of its Class A common stock with institutional investors. The company issued 6,500,000 shares at $0.34 per share in this unregistered offering, generating approximately $2.21 million in gross proceeds before fees and expenses.
The parties also amended their Registration Rights Agreement to extend the deadline for filing a registration statement covering the resale of these shares to 5:30 p.m. Eastern Time on June 18, 2026. The shares were sold in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation D and cannot be freely resold in the United States without registration or a further exemption.
Volato Group, Inc. entered into a Securities Purchase Agreement on June 7, 2026 to sell 6,500,000 shares of its Class A common stock at $0.34 per share, for expected gross proceeds of about $2.21 million. The transaction is an unregistered private placement relying on Section 4(a)(2) and Regulation D.
The deal is led by Catheter Precision, Inc. and other institutional investors, and closing depends on customary conditions, including NYSE American approval of a supplemental listing application and delivery of specified third-party securities to Catheter Precision. Volato also granted investors registration rights to resell the shares and agreed not to enter into Variable Rate Transactions for nine months, while highlighting a renewed strategic focus on AI infrastructure and related acquisition opportunities.
Volato Group, Inc. has terminated its previously announced merger agreement with M2i Global, Inc. after the deal was not completed by the outside closing date of March 31, 2026. Volato delivered written notice of termination on June 4, 2026 and will not pay any termination fee or penalty.
The company ended the transaction as part of a broader review of strategic alternatives. It has received unsolicited letters of intent that it believes may offer greater value for shareholders than the terminated merger and is evaluating other potential strategic transactions. Volato cautions that there is no assurance any discussions or evaluations will lead to a definitive agreement or completed deal and highlights risks including potential adverse business effects and maintaining compliance with NYSE American listing requirements.
Volato Group, Inc. reports that NYSE American has accepted its plan to regain compliance with the exchange’s continued listing standards. The approval allows Volato’s Class A common stock to keep trading on NYSE American while the company works under a plan period through December 17, 2026.
The company previously fell out of compliance after reporting a stockholders’ deficit as of December 31, 2025 and recording losses from continuing operations and/or net losses in three of its four most recent fiscal years. If Volato does not regain compliance or show sufficient progress under the plan by December 17, 2026, NYSE American may initiate delisting proceedings.
Volato Group, Inc. Schedule 13G filed by Clearthink Capital Partners, LLC reports beneficial ownership of 2,807,925 shares of common stock, representing 5.36% of the outstanding shares. The filer certifies the holdings were acquired in the ordinary course of business and not to influence control.
Volato Group, Inc. reported the final results of its virtual special meeting held May 7, 2026, where shareholders approved a merger with M2i Global and related governance measures. As of the April 17, 2026 record date there were 38,903,163 shares outstanding; 15,140,570 shares (approximately 38.92%) were present or represented by proxy, constituting a quorum.
Stockholders approved: (1) the Merger Agreement and transactions thereunder; (2) issuance of 20% or more of outstanding shares as merger consideration (change of control); (3) election of seven directors for the combined company; (4) a name change to M2i Global, Inc.; (5) the M2i Global, Inc. 2026 Stock Incentive Plan; and (6) authorization for a reverse stock split between 1-for-2 and 1-for-25 (board discretion). The Merger is expected to be consummated subject to satisfaction or waiver of closing conditions described in the Merger Agreement and proxy materials.